Furthermore, we analysed the Oncoprint map of HCC patient genes in the TCGA dataset by using the cBioPortal map (Fig. 1D), and the results showed that gene amplification and missense mutations of DLGAP4 were less than 1.4%. This evidence concerns the gene DLGAP4 and hepatocellular carcinoma.